MEMPHASYS LIMITED. — Regulatory Filings 2012

Jun 4, 2012

==> picture [196 x 25] intentionally omitted <==

==> picture [196 x 24] intentionally omitted <==

==> picture [196 x 25] intentionally omitted <==

==> picture [196 x 25] intentionally omitted <==

==> picture [230 x 46] intentionally omitted <==

FOR IMMEDIATE RELEASE

NuSep Further Expands Gels Distribution with Appointment of BioExpress in the US

Sydney, Australia 5[th] June 2012 - NuSep (ASX: NSP) is pleased to advise the market that it has appointed BioExpress Inc (www.BioExpress.com) to distribute the Company’s Gels in the US.

BioExpress is a leading US distributor of equipment, consumables, reagents and lab essentials into the US life science research marketplace. They have over 35 Molecular Biology trained sales people selling nationwide. BioExpress is also the preferred supplier to several US academic institutions, which opens up a number of new markets for NuSep.

The NuSep Gels complement BioExpress’ existing product range enabling BioExpress to complete its electrophoresis product offering. BioExpress will launch the Gels this month.

This new expanded distribution agreement will significantly expand NuSep’s access to the key US market. The Company anticipates that BioExpress will generate more than $250,000 of gels sales to NuSep in the first full year. NuSep estimates that the US Analytical Gel market is worth $60m pa.

Dr Hari Nair, Managing Director of NuSep said that “This is a significant achievement for NuSep as it strengthens our relationship with one of the premier Life Science companies in the US and broadens the reach for our Gel products. We look forward to a long and mutually beneficial business partnership with BioExpress”.

Mr John Manusu, NuSep’s Executive Chairman said, “The BioExpress appointment further strengthens our distribution network and is a significant step towards our goal to achieve a 10% market share of the Gels market”.

Randy Scott, President/CEO of BioExpress said that “We are pleased to distribute the NuSep Gels, as they compliment our product offering perfectly and expect these products to generate significant sales for us over the coming years”.

ENDS

For more information please contact:

Contact: Prakash Patel Chief Operating Officer +61 2 8415 7300 prakash.patel@nusep.com

Contact Details Telephone +61 2 8415 7300 Facsimile +61 2 8415 7399

Email info@nusep.com Web www.nusep.com ABN 33 120 047 556

NuSep Holdings Ltd 324 Burns Bay Rd Lane Cove NSW 2066

Postal Address P.O. Box 823 Lane Cove NSW 1595

– 2 –

About NuSep

NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global BioSeparations market. NuSep recently acquired BioInquire which developed the ProteoIQ software enabling NuSep to offer a total Proteomics solution from Fraction to Function . The company has offices in both Sydney Australia and Atlanta, USA.

With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification.

NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.

NuSep Products:

==> picture [12 x 17] intentionally omitted <==

• Gels – NuSep manufactures and sells precast gels including the innovative nUView Gels, which can be visualised 2 minutes after use.

==> picture [12 x 17] intentionally omitted <==

• Separation Instruments – NuSep has developed two unique biological separation instruments. The ProteomeSep was released in 2009 and can separate biological samples into 8 fractions for use in the proteomic market. The SpermSep separates sperm for fertility treatments such as IVF.

==> picture [12 x 17] intentionally omitted <==

• Proteomics Software – NuSep offers the unique ProteoIQ software for the analysis of complex mass spec samples. This software is also designed to identify bio markers.

==> picture [12 x 17] intentionally omitted <==

• Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin .

For more information about NuSep please visit the company’s website www.NuSep.com

About PrIME Biologics Pte Ltd

PrIME Biologics is a Singapore based biotech company that has developed a disposable procedure for the processing of plasma proteins. PrIME Biologics is currently a wholly owned subsidiary of NuSep Holdings Limited (ASX: NSP). PrIME Biologics process is based on the Pr eparative I solation by M embrane E lectrophoresis (PrIME) technology developed by NuSep. PrIME provides disposable modular processing that is ‘electronically’ driven membrane fractionation.

The PrIME process increases product yields to over 90% relative to the existing process 50% while increasing product safety. The PrIME has been shown to remove virus, bacteria, endotoxins and prions which cause ‘Mad Cow Disease’. Further, PrIME Biologics process can produce multiple plasma products in hours compared to days, which is required by the current manufacturers.

The initial application for the PrIME process will be the Currently Unprocessable Plasma which represents approximately 50% of all the plasma collected in many countries.

About BioExpress Inc

BioExpress is a leading distributor of equipment, consumables, reagents and lab essentials in the life science research marketplace. BioExpress offers a wide range of well known brands, such as GeneMate, Corning, Eppendorf, Labnet and Greiner Bio-One. BioExpress has a nationwide sales team, aggressive marketing programs and initiatives and have positioned itself to be the best company to bring new brands and products to the US life science marketplace.